Carcinoembryonic Antigen (CEA) / CD66 Antibody, IgG2a, Clone: [C66/1009], Mouse, Monoclonal

Artikelnummer: NBT-1048-MSM5-CF488-100T
Artikelname: Carcinoembryonic Antigen (CEA) / CD66 Antibody, IgG2a, Clone: [C66/1009], Mouse, Monoclonal
Artikelnummer: NBT-1048-MSM5-CF488-100T
Hersteller Artikelnummer: 1048-MSM5-CF488-100T
Alternativnummer: NBT-1048-MSM5-CF488-100T-0.5,NBT-1048-MSM5-CF488-100T-500
Hersteller: NeoBiotechnologies
Wirt: Mouse
Kategorie: Antikörper
Applikation: FC, IF
Spezies Reaktivität: Human
Immunogen: Recombinant full-length human CEA protein
Alternative Synonym: Carcinoembryonic Antigen-related Cell Adhesion Molecule 5, CEACAM5, CD66, Biliary Glycoprotein (BGP-1)
This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.
Klonalität: Monoclonal
Klon-Bezeichnung: [C66/1009]
Molekulargewicht: 80-200kDa
Isotyp: IgG2a
NCBI: 1048
UniProt: P06731
Formulierung: Antibody purified from Bioreactor Concentrate by Protein A/G and conjugated to various reporter molecules. Prepared in 10mM PBS with 0.05% BSA and 0.05% azide. Contact us if you require this Ab in a different format.
Antibody Type: Monoclonal Antibody
Anwendungsbeschreibung: Flow Cytometry (5ul per test per one million cells or 5ul per 100ul of whole blood),Immunofluorescence (1:50-1:100),Optimal dilution for a specific application should be determined.